Notice: Podravka d.d. Supervisory Board session held

Pursuant to the Capital Market Law and the Rules of the Zagreb Stock Exchange, we hereby inform you that Podravka d.d. Supervisory Board Session was held on 20^th December 2012. At this session Podravka d.d. Supervisory Board consented to Podravka Group Business Plan for 2013, along with the Podravka Group Strategy for the upcoming five-year period. Emphasis is on increased operating efficiency of business, profitable growth, with additional strengthening of positions on domestic and key foreign markets.

Considering that Podravka stocks are listed in the Official market of the Zagreb Stock Exchange, with the purpose of more favourable financing, Podravka will try to ensure financing in the capital market.

At the same session, as suggested by the Management Board president, it is decided that Podravka Management Board be added with another member, with the purpose of strengthening of Podravka Group pharmaceutical part of business and for better synergy between the food processing and pharmaceutical segment of business. Podravka d.d. Supervisory Board appointed Hrvoje Kolarić as the new member of Podravka d.d. Management Board, as of 20^th December 2012.
Mr. Hrvoje Kolarić will continue to perform his duties as President of the Management Board of Belupo d.d.

 Hrvoje Kolarić graduated in 1998 from the Faculty of Pharmacy and Biochemistry in Zagreb, and in  2011 he received his MBA from IEDC Bled. In his business career he was a director of BMS Pharmaceuticals, product niche and business development, then a director of PharmaSwiss d.o.o. Croatia, a manager at Bristol - Mayers Squibb branch office for Croatia and Bosnia& Herzegovina, then a manager for allergy and respiratory products at Schering Plough branch office in Croatia.

He was appointed Belupo d.d. Management Board member in May 2005, and in May 2012 he was appointed Belupo d.d. Management Board president.